Beneficial Effects of Resveratrol Consumption in Type 1 Diabetes patients

Evaluation of effects of resveratrol in reducing blood glucose in type 1 diabetes patients: by using before and after exploratory trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201710108129N11

Enrollment

Registered

2017-11-07

Start date

2017-10-12

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes. type 1 diabetes

Interventions

consumed orally and for a period of 60 days.

The intervention group(500 mg / twice daily of Resveratrol capsules )

morning and evening

consumed orally and for a period of 60 days..

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

12 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients with T1DM; subjects with good peripheral vein; patients on insulin treatment as long as they are on stable doses and the dosage is not changed during the course of the study. Exclusion Criteria: Subjects on any antioxidant therapy such as vitamin supplements; having an allergy to grapes; green tea; and peanuts; patients with type 2 diabetes; pregnant women; lactating mothers; severe heart disease; hepatic disease; renal dysfunction and smoking.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: Before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By Boronate Affinity Assay.;FBS. Timepoint: Before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: by enzymatic method.	—

Secondary

Measure	Time frame
Glucagon. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By ELISA Method- Kits.;Frutosamin. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By ELISA Method- Kits.;Blood Urea. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.;Albumin. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.;Creatinine. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.	—

Measure

Time frame

Glucagon. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By ELISA Method- Kits.;Frutosamin. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By ELISA Method- Kits.;Blood Urea. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.;Albumin. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.;Creatinine. Timepoint: before the intervention, one month later, two months after the beginning of the intervention and finally one month later. Method of measurement: By reliable Kits.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Movahed

Bushehr university of medical sciences, Moallem ST, Bushehr, Iran

amovahed58@gmail; comamirali_1957@yahoo.com+98 77 3332 4044

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026